CATAFLAM Safety Questions, CATAFLAM Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CATAFLAM. Our extensive database of CATAFLAM adverse events and CATAFLAM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CATAFLAM
CATAFLAM Safety Reports
Total CATAFLAM reports: 23.CATAFLAM FDA safety alerts: No.
Reported hospitalizations: 7.
Take CATAFLAM Side Effects Survey or Share Your CATAFLAM Story. CATAFLAM Usage.
Consumer or non-health professional from UNITED STATES reported CATAFLAM problem on Mar 02, 2007. Female patient, 64 years of age, weighting 200.0 lb, was diagnosed with arthritis and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: groin pain, muscle injury, muscle spasms. CATAFLAM dosage: unknown. Patient recovered.
CATAFLAM problem was reported by a Physician from GUATEMALA on Mar 28, 2007. Female patient was diagnosed with pyrexia and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, urine analysis abnormal. CATAFLAM dosage: unknown. Patient recovered.
Health Professional from VENEZUELA reported CATAFLAM problem on May 04, 2007. Male patient, weighting 20.50 lb, was diagnosed with tonsillitis, pyrexia and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: hypothermia. CATAFLAM dosage: unknown. During the same period patient was treated with AMOXICILLIN, DEXTROMETHORPHAN, TYLENOL. Patient was hospitalized. Patient recovered.
CATAFLAM problem was reported by a Consumer or non-health professional from BRAZIL on May 14, 2007. Male patient, child 3 years of age, weighting 26.46 lb, was diagnosed with pharyngitis, cough and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, depressed mood, faeces pale, hypotension, peripheral coldness, poisoning, vomiting. CATAFLAM dosage: unknown. During the same period patient was treated with CARBOCISTEINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported CATAFLAM problem on May 22, 2007. Female patient, child 4 years of age, weighting 33.07 lb, was diagnosed with pharyngolaryngeal pain and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: impetigo, pharyngolaryngeal pain, pyrexia. CATAFLAM dosage: unknown. Patient recovered.
CATAFLAM problem was reported by a Consumer or non-health professional from BRAZIL on May 24, 2007. Male patient, child 5 years of age, weighting 33.07 lb, was diagnosed with pharyngolaryngeal pain, convulsion and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hyponatraemia, laziness, nasopharyngitis, pneumonia, pyrexia, vomiting. CATAFLAM dosage: unknown. During the same period patient was treated with RIVOTRIL, VALPROATE. Patient recovered.
Consumer or non-health professional from BRAZIL reported CATAFLAM problem on May 29, 2007. Male patient, child 3 years of age, weighting 26.46 lb, was diagnosed with pharyngitis, cough, pneumonia and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, depressed mood, faeces pale, hypotension, peripheral coldness, poisoning, vomiting. CATAFLAM dosage: unknown. During the same period patient was treated with CARBOCISTEINE, ANTIBIOTICS. Patient was hospitalized. Patient recovered.
CATAFLAM problem was reported by a Physician from ECUADOR on June 19, 2007. Male patient, 65 years of age, was diagnosed with infection and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, syncope, vision blurred. CATAFLAM dosage: 50 MG, Q12H. During the same period patient was treated with DICLOFENAC, BIODROXIL, CORTICOSTEROID NOS. Patient recovered.
Physician from MALTA reported CATAFLAM problem on July 20, 2006. Male patient, 61 years of age, weighting 165.3 lb, was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic decreased, cardiac pacemaker insertion, dyspnoea exertional, fatigue, mass, ventricular dysfunction. CATAFLAM dosage: 50 MG, TID. During the same period patient was treated with ENALAPRIL MALEATE, ASPIRIN. Patient recovered.
CATAFLAM problem was reported by a Physician from MALTA on July 20, 2006. Male patient, 61 years of age, weighting 165.3 lb, was diagnosed with back pain and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic decreased, bundle branch block left, cardiac pacemaker insertion, dyspnoea exertional, fatigue, mass, myocardial ischaemia, somnolence, ventricular dysfunction. CATAFLAM dosage: 50 MG, TID. During the same period patient was treated with ENALAPRIL MALEATE, ASPIRIN. Patient recovered.
Consumer or non-health professional from BRAZIL reported CATAFLAM problem on Aug 23, 2006. Male patient, 36 years of age, weighting 173.9 lb, was diagnosed with pharyngitis and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: haemoptysis. CATAFLAM dosage: unknown. Patient recovered.
CATAFLAM problem was reported by a Physician from VENEZUELA on Mar 28, 2006. Male patient, child 7 years of age, was diagnosed with pyrexia and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: coagulopathy, dyspnoea, encephalitis, eyelid oedema, pneumonitis, thrombocytopenia, urticaria, white blood cell count increased. CATAFLAM dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ACYCLOVIR, BENADRYL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported CATAFLAM problem on Mar 15, 2006. Female patient, 55 years of age, was diagnosed with back pain and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, dizziness, nausea. CATAFLAM dosage: unknown. Patient recovered.
CATAFLAM problem was reported by a Health Professional from MALTA on Sept 04, 2006. Female patient, 75 years of age, weighting 198.4 lb, was diagnosed with pain and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: haemorrhage. CATAFLAM dosage: 150MG DAILY. During the same period patient was treated with ENALAPRIL, ISTIN. Patient recovered.
Health Professional from MALTA reported CATAFLAM problem on Sept 04, 2006. Female patient, 75 years of age, weighting 198.4 lb, was diagnosed with pain and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: gastric haemorrhage. CATAFLAM dosage: 150MG DAILY. During the same period patient was treated with ENALAPRIL, ISTIN. Patient recovered.
CATAFLAM problem was reported by a Consumer or non-health professional from VENEZUELA on Oct 10, 2006. Male patient, weighting 20.50 lb, was diagnosed with tonsillitis, pyrexia and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: hypothermia. CATAFLAM dosage: unknown. During the same period patient was treated with AMOXICILLIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from MALTA reported CATAFLAM problem on July 18, 2007. Male patient, 32 years of age, was diagnosed with pain and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: dysarthria, somnolence. CATAFLAM dosage: 50 MG, TID. During the same period patient was treated with VOLTAREN. Patient recovered.
CATAFLAM problem was reported by a Consumer or non-health professional from MALTA on July 25, 2007. Male patient, 32 years of age, was diagnosed with pain and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: dysarthria, somnolence. CATAFLAM dosage: 50 MG, BID. Patient recovered.
Consumer or non-health professional from BRAZIL reported CATAFLAM problem on Aug 08, 2007. Female patient, 44 years of age, weighting 238.1 lb, was diagnosed with pharyngitis and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, obstructive airways disorder. CATAFLAM dosage: unknown. Patient recovered.
CATAFLAM problem was reported by a Physician from BRAZIL on Aug 29, 2007. Female patient, 13 years of age, weighting 83.78 lb, was diagnosed with pharyngolaryngeal pain, hypersensitivity and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, exposure to toxic agent, eye swelling, lip swelling, pharyngeal oedema. CATAFLAM dosage: unknown. During the same period patient was treated with DIPYRONE, PESTICIDE. Patient was hospitalized. Patient recovered.
Physician from MALTA reported CATAFLAM problem on Aug 29, 2007. Female patient, 31 years of age, was diagnosed with pulpitis dental and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: burn oesophageal, gastric lavage. CATAFLAM dosage: 50MG ONCE. Patient recovered.
CATAFLAM problem was reported by a Physician from BRAZIL on Sept 04, 2007. Female patient, 13 years of age, weighting 83.78 lb, was diagnosed with pharyngolaryngeal pain, hypersensitivity and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, exposure to toxic agent, eye swelling, lip swelling, pharyngeal oedema. CATAFLAM dosage: unknown. During the same period patient was treated with DIPYRONE, PESTICIDE. Patient was hospitalized. Patient recovered.
Physician from MALTA reported CATAFLAM problem on Aug 29, 2007. Female patient, 31 years of age, was diagnosed with pulpitis dental and was treated with CATAFLAM. After drug was administered, patient experienced the following problems/side effects: burn oesophageal, gastric lavage. CATAFLAM dosage: 50MG ONCE. Patient recovered.
